BHVN
BHVN
NYSE · Biotechnology

Biohaven Ltd

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$13.50
-0.32 (-2.32%)
As of Aug 8, 1:38 AM ET ·
Analyst Consensus
Strong Buy
25
Analysts
High
Coverage
Buy 19 76%
Hold 5 20%
Sell 1 4%
Price Target
Analyst Price Target +122.7% upside
Low Target $17.22
Average Target $30.06
High Target $35.82
Current Price $13.50
Current
$13.50
Target
$30.06
$17.22 $30.06 avg $35.82
Scenario Analysis
Bear Case
$17.22
27.6%
Low target
Base Case
$30.06
+122.7%
Avg target
Bull Case
$35.82
+165.3%
High target
Risk/Reward
6.0x
Highly favorable
Price in Context
52-Week High
$18.57
-27.3% from high
52-Week Low
$7.48
+80.5% from low
Target vs 52W High
$30.06
+61.9% vs high
Next Earnings Report
Aug 10, 2026
1d
tomorrow
EPS Est: $-0.75
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 44 64% $91.45 -56.0%